KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Payables (2016 - 2025)

Historic Payables for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to $52.2 million.

  • Teladoc Health's Payables rose 3808.63% to $52.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.2 million, marking a year-over-year increase of 3808.63%. This contributed to the annual value of $33.1 million for FY2024, which is 2407.82% down from last year.
  • Teladoc Health's Payables amounted to $52.2 million in Q3 2025, which was up 3808.63% from $54.4 million recorded in Q2 2025.
  • In the past 5 years, Teladoc Health's Payables ranged from a high of $94.4 million in Q2 2022 and a low of $16.1 million during Q2 2023
  • Moreover, its 5-year median value for Payables was $43.6 million (2023), whereas its average is $45.6 million.
  • Per our database at Business Quant, Teladoc Health's Payables surged by 32221.81% in 2021 and then plummeted by 8297.04% in 2023.
  • Over the past 5 years, Teladoc Health's Payables (Quarter) stood at $47.3 million in 2021, then rose by 0.92% to $47.7 million in 2022, then decreased by 8.5% to $43.6 million in 2023, then dropped by 24.08% to $33.1 million in 2024, then surged by 57.56% to $52.2 million in 2025.
  • Its last three reported values are $52.2 million in Q3 2025, $54.4 million for Q2 2025, and $52.1 million during Q1 2025.